Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 244

Posts Tagged ‘genetics’

Bophelo Partners with DNA Genetics in Lesotho

Posted by fidest press agency su martedì, 7 gennaio 2020

Toronto, Ontario Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that Bophelo Bioscience & Wellness (“Bophelo”) has signed a strategic alliance and seed purchase agreement with OG DNA Genetics Inc. (“DNA Genetics” or “DNA”), to give the Bophelo exclusive rights to develop new and existing DNA Genetics’ strains of medical cannabis in Lesotho (the “Strategic Alliance”) for worldwide exportation.Halo signed a definitive agreement to acquire Bophelo on November 27th, 2019. The acquisition of Bophelo by Halo is expected to close within the next 30 days.DNA is one of the world’s leading creators of high-quality cannabis seeds, whose strains consistently contain high cannabinoid and terpene concentrations. DNA’s cannabis strains already command premium market prices in Canada, the United States and Europe and are some of the most sought-after strains and seeds in the world.Under the terms of the Strategic Alliance, Bophelo is the only company in Lesotho that has the right to grow and develop DNA’s strains of cannabis through breeding, cultivation, phenotyping and prompt regulatory certification.
Louisa Maliako Mojela, Chairman of Bophelo, commented, “Bophelo’s strategic alliance with DNA Genetics in Lesotho gives us a significant competitive edge, as we strive to become one of the world’s leading exporters of medical cannabis and related products.
Our vision is to create the largest medical cannabis cultivation zone on the planet at Bophelo. This is fast becoming a reality. The maiden harvest of 1,000 plants is on course for early Q2 2020, the first phase of greenhouse construction nearing completion and we are securing international GACP certification for our site. The alliance with DNA is even further validation of how rapidly our Lesotho operations have developed and the unlimited potential of this opportunity. Now, with the introduction of DNA’s award-winning world-class cannabis strains, we can accelerate our breeding program to grow medical-grade cannabis in very large quantities at Bophelo, which will command premium export prices.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Bophelo Partners with DNA Genetics in Lesotho

Posted by fidest press agency su domenica, 5 gennaio 2020

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that Bophelo Bioscience & Wellness (“Bophelo”) has signed a strategic alliance and seed purchase agreement with OG DNA Genetics Inc. (“DNA Genetics” or “DNA”), to give the Bophelo exclusive rights to develop new and existing DNA Genetics’ strains of medical cannabis in Lesotho (the “Strategic Alliance”) for worldwide exportation.
Halo signed a definitive agreement to acquire Bophelo on November 27th, 2019. The acquisition of Bophelo by Halo is expected to close within the next 30 days. DNA is one of the world’s leading creators of high-quality cannabis seeds, whose strains consistently contain high cannabinoid and terpene concentrations. DNA’s cannabis strains already command premium market prices in Canada, the United States and Europe and are some of the most sought-after strains and seeds in the world.
Under the terms of the Strategic Alliance, Bophelo is the only company in Lesotho that has the right to grow and develop DNA’s strains of cannabis through breeding, cultivation, phenotyping and prompt regulatory certification.
Louisa Maliako Mojela, Chairman of Bophelo, commented, “Bophelo’s strategic alliance with DNA Genetics in Lesotho gives us a significant competitive edge, as we strive to become one of the world’s leading exporters of medical cannabis and related products.Our vision is to create the largest medical cannabis cultivation zone on the planet at Bophelo. This is fast becoming a reality. The maiden harvest of 1,000 plants is on course for early Q2 2020, the first phase of greenhouse construction nearing completion and we are securing international GACP certification for our site. The alliance with DNA is even further validation of how rapidly our Lesotho operations have developed and the unlimited potential of this opportunity.Now, with the introduction of DNA’s award-winning world-class cannabis strains, we can accelerate our breeding program to grow medical-grade cannabis in very large quantities at Bophelo, which will command premium export prices.”

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Halo Partners with DNA Genetics to Launch Leading World-Renowned Genetics in Oregon

Posted by fidest press agency su venerdì, 13 dicembre 2019

Toronto, Ontario – December 8, 2019 – Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has signed a strategic partnership agreement with OG DNA Genetics Inc. (“DNA Genetics”), one of the most awarded names in cannabis, to exclusively develop its genetics in Oregon through breeding, growing, phenotyping and processing. The initial term of the partnership agreement is five years with successive five-year renewals.DNA Genetics has garnered over 180 awards in the cannabis industry including High Times top 10 strain of the year, seedbank Hall of Fame, and Trail Blazers award Their strains and derivative products command a premium in the market and are highly demanded by cannabis consumers 5-year exclusive partnership will expand on Halo’s already prominent genetics library to establish a new standard of cannabis in Oregon Partnership aligns with the 1 acre increase in the grow operation in East Evans Creek Halo will be only grower and manufacturer of DNA Genetics brand products in Oregon. Founded in Amsterdam in 2004, DNA Genetics is a leading influencer in the global cannabis industry, developing high-quality seeds using a professional, responsible and technical approach. DNA Genetics created some of the most well-known products by combining high quality genetics and expert growing practices. With a win in every single category of the HIGH TIMES Cannabis Cup, many of the top seed companies in the industry use DNA within their breeding programs.DNA will take that expertise and award-winning track record to produce strains that will be exclusive to Halo in the state of Oregon. The exclusivity requires that companies in Oregon that seek access to the DNA strains must license them from Halo.Andreas Met, Co-founder and COO of Halo commented, “We have seen that consumers demand quality and the top brands in our industry. DNA Genetics provides just that. We expect that demand for our products across the board will benefit from the co-branding opportunities this alliance presents.” Mr. Met went on to state, “Our recent cultivation expansion provides us an opportunity to capitalize on the DNA Genetics partnership. We will refine genetics of the cannabis that Halo currently produces while introducing new DNA strains into circulation.” Commenting on the full potential Kiran Sidhu, Co-founder and CEO of Halo said, “We are excited to partner with DNA Genetics to build upon our strains in Oregon. DNA Genetics is renowned through the cannabis industry as a top breeder. Having exclusive rights to their genetic developments in Oregon reaffirms our leading position in this market and will help the Oregon market reach new heights.” He added, “We hope this is the first of many markets in which Halo and DNA will collaborate.”

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Seattle Genetics to Present at the J.P. Morgan Healthcare Conference

Posted by fidest press agency su venerdì, 21 dicembre 2018

Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 2:30 p.m. Pacific Time. Both the presentation and question and answer session that follows at 3:00 p.m. will be webcast live and available for replay from Seattle Genetics’ website at http://www.seattlegenetics.com in the Investors section.
Seattle Genetics, Inc. is an emerging multi-product, global biotechnology company that develops and commercializes transformative therapies targeting cancer to make a meaningful difference in people’s lives. ADCETRIS® (brentuximab vedotin) utilizes the company’s industry-leading antibody-drug conjugate (ADC) technology and is currently approved for the treatment of multiple CD30-expressing lymphomas. Beyond ADCETRIS, the company has established a pipeline of novel targeted therapies at various stages of clinical testing, including three in ongoing pivotal trials for solid tumors. Enfortumab vedotin for metastatic urothelial cancer and tisotumab vedotin for metastatic cervical cancer utilize our proprietary ADC technology. Tucatinib, a small molecule tyrosine kinase inhibitor, is in a pivotal trial for HER2-positive metastatic breast cancer. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents in clinical trials targeting hematologic malignancies and solid tumors. The company is headquartered in Bothell, Washington, and has a European office in Switzerland. For more information on our robust pipeline, visit http://www.seattlegenetics.com and follow @SeattleGenetics on Twitter.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Pavia: Erasmus Mundus

Posted by fidest press agency su mercoledì, 22 settembre 2010

Pavia 23 settembre 2010, ore 11,00 Sala del Consiglio, Rettorato dell’Università degli studi  si terrà un incontro, aperto alla stampa con i  primi 9 studenti provenienti dall’America Latina (Costa Rica, Colombia, Panama) che partecipano al progetto Erasmus Mundus dell’Università di Pavia. Si tratta di un progetto europeo grazie al quale studenti provenienti dall’America Latina, Colombia, Costa Rica e Panama, hanno l’opportunità di trascorrere un periodo tra i 6 e i 34 mesi all’Università di Pavia per frequentare i corsi di laurea di ingegneria, i corsi di laurea in lingua inglese in Molecular  Biology and Genetics e in International Business and Economics, oltre ai corsi di dottorato in varie discipline. A dare il benvenuto ai nuovi studenti sudamericani, il prof. Andrea Giuseppe Capodaglio, responsabile del progetto per l’Ateneo pavese che illustrerà il percorso didattico e le attività previste da Erasmus Mundus.

Posted in Cronaca/News, Università/University | Contrassegnato da tag: , , , | Leave a Comment »